The 'A-Team' of Vaccine Companies: Acambis, AVANT and Aviron

Author：

ISSN： 1537-1328

Source： Pharmaceutical Innovation, Vol.11, Iss.4, 2002-06, pp. : 44-49

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Influenza Virus Vaccine Live Intranasal -Aviron: Flumist, Influenza Vaccine Live Intranasal

Drugs in R&D, Vol. 3, Iss. 2, 2002-02 ,pp. : 123-129

Adis International

Access to resources Recommend Favorite

Rotavirus Vaccine AVANT Immunotherapeutics/GlaxoSmithKline: 89-12, RIX4414

By Adis International Limited

Drugs in R&D, Vol. 5, Iss. 2, 2004-01 ,pp. : 113-115

Adis International

Access to resources Recommend Favorite

Vaccines for Emerging Infectious Diseases: The Accomplishments of Acambis

By Adis International Limited

Pharmaceutical & Diagnostic Innovation, Vol. 4, Iss. 12, 2006-01 ,pp. : 12-15

Adis International

Access to resources Recommend Favorite

Direct Evidence on the Immune-Mediated Spontaneous Regression of Human Cancer: An Incentive for Pharmaceutical Companies to Develop a Novel Anti-Cancer Vaccine

Current Pharmaceutical Design, Vol. 11, Iss. 27, 2005-10 ,pp. : 3531-3543

Bentham Science Publishers

Access to resources Recommend Favorite

Companies in this Issue

Pharmaceutical Innovation, Vol. 12, Iss. 3, 2003-04 ,pp. : 53-54

Adis International

Access to resources Recommend Favorite